Health Effects of Different Types of Bread (HELFAB)

May 11, 2021 updated by: Oslo Metropolitan University

Health Effects and Consumer Aspects of Different Types of Bread

Dietary fiber is well known to have health promoting effects, including reduced blood glucose and cholesterol levels. Bread is the most important source of dietary fiber in the Norwegian diet. Production of bread has changed from the traditionally use of sourdough, to yeast (Saccharomyces cerevisiae) as the dominating leavening agent in modern industrial production. Sourdough naturally contains bacteria, and through the fermentation process these bacteria release several components that are not found in modern bread using yeast. It has been shown that sourdough may have positive health effects, including on blood glucose regulation. The aim of the project is to investigate if intake of sourdough may give positive health effects compared to beard with yeast.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The investigators aim to include approximately 20 participants in this randomized controlled double-blind cross-over study lasting for 5 weeks.

All participants will be given bread baked with yeast for a 2 weeks run-in period. The participants will then be randomly assigned to either 1 week intervention with bread baked with yeast or sourdough, before a 1 week wash-out period with yeast bread. During the last 1 week intervention period the participants starting with bread baked with yeast will be given sourdough and vice versa.

Questionnaires (GSRS-IBS, BSC, FFQ), blood samples, and feces samples will be collected before and after the intervention periods.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0130
        • Vibeke Telle-Hansen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • healthy adults who restrict their intake of bread due to stomach ache.

Exclusion Criteria:

  • Chronic metabolic diseases, such as diabetes type 1 or 2, cardiovascular diseases and cancer last 6 months
  • Gut diseases, including Chron's disease, ulcers colitis
  • Food allergies or intolerance
  • Pregnant and/or lactating
  • Smokers
  • BMI <18,5 and >27 kg/m2
  • Planed weight reduction and/or ± 5% weight change last 3 months
  • Blood donor last 2 months and during the study period
  • Not willing to quit taking dietary supplements, including probiotics, cod liver oil etc., 4 weeks prior to study start and during the study
  • Use of antibiotics <3 months prior to study start and during the study
  • Alcohol intake >40 g/day
  • Hormone treatment (except contraceptives)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Wholegrain bread with yeast
The control group will be given min. 5 slices of bread baked with yeast per day.
intervention group: bread with sourdough control group: bread with yeast
Experimental: Wholegrain bread with sourdough
The experimental group will be given min. 5 slices of bread baked with sourdough per day.
intervention group: bread with sourdough control group: bread with yeast

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gastrointestinal Symptom Rating Scale-irritable bowl syndrome (GSRS-IBS)
Time Frame: 5 weeks
GSRS-IBS analysis after intervention with bread baked with yeast versus sourdough with the following response scale: 1 (no discomfort at all) to 7 (very severe discomfort)
5 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bristol stool chart (BSC)
Time Frame: 5 weeks
BSC analyses after intervention with bread baked with yeast versus sourdough with a scale from 1 (separate hard lumps, like nuts) to 7 (watery, no solid pieces)
5 weeks
Blood C-peptide, total cholesterol, triglycerides, fatty acid profile, and short chain fatty acids
Time Frame: 5 weeks
Blood analyses of C-peptide, total cholesterol, triglycerides, fatty acid profile, and short chain fatty acids after intervention with bread baked with yeast versus sourdough
5 weeks
Feces microbiota analysis performed with Bio-Me's Precision Microbiome Profiling platform (PMP™)
Time Frame: 5 weeks
Feces analyses of microbiota after intervention with bread baked with yeast versus sourdough
5 weeks
Iron, selenium and zinc in blood
Time Frame: 5 weeks
Blood analysis of iron, selenium and zinc after intervention with bread baked with yeast versus sourdough
5 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vibeke Telle-Hansen, PhD, Oslo and Akershus University College

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2020

Primary Completion (Actual)

December 20, 2020

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

November 26, 2020

First Submitted That Met QC Criteria

December 16, 2020

First Posted (Actual)

December 21, 2020

Study Record Updates

Last Update Posted (Actual)

May 12, 2021

Last Update Submitted That Met QC Criteria

May 11, 2021

Last Verified

October 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 96264

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on IBS

Clinical Trials on Intervention group

3
Subscribe